SCHEMBL7769235

SCHEMBL7769235

COc1ccccc1N1CCN(C(N)Cc2nc3c(Cl)cccc3s2)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR7 P34969 2/20 0.44
HTR6 P50406 1/20 0.44
TSHR P16473 6/20 0.43
LMNA P02545 5/20 0.43
ALDH1A1 P00352 2/20 0.43
PPARG P37231 1/20 0.43
RAB9A P51151 1/20 0.43
NCOA2 Q15596 1/20 0.43
NCOA1 Q15788 1/20 0.43
NCOA3 Q9Y6Q9 1/20 0.43
HTT P42858 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
GAA P10253 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
POLB P06746 1/20 0.42
ADRA1D P25100 1/20 0.41
ADRA1A P35348 1/20 0.41
ADRA1B P35368 1/20 0.41
MAPK1 P28482 1/20 0.41
KMT2A Q03164 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL7769214 0.99 HTR7 (0.43) HTR7HTR6TSHRLMNAALDH1A1
SCHEMBL7769232 0.92 ALDH1A1 (0.51) HTR7HTR6TSHRLMNAALDH1A1
Bromide SCHEMBL7773371 0.91 ALDH1A1 (0.50) HTR7HTR6TSHRLMNAALDH1A1
SCHEMBL7773363 0.89 HTR7 (0.46) HTR7HTR6TSHRALDH1A1PPARG
Bromide SCHEMBL7773418 0.89 HTR7 (0.45) HTR7HTR6TSHRALDH1A1PPARG
SCHEMBL7769224 0.86 RAB9A (0.49) HTR7TSHRALDH1A1PPARGRAB9A
SCHEMBL7856190 0.80 POLB (0.45) TSHRALDH1A1RAB9APOLBMAPK1
SCHEMBL7984291 0.79 TSHR (0.44) HTR7HTR6TSHRLMNAALDH1A1
SCHEMBL7769229 0.79 HTR7 (0.46) HTR7TSHRLMNAALDH1A1HTT
Fumaric Acid SCHEMBL7773337 0.79 MAPT (0.48) HTR7TSHRLMNAALDH1A1PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1325397-A 2-piperazino alkylatnino benzoazole derivatives: dopamine receptor subtype sepcific ligands NEUROGEN CORP (US) 2001-12-05 CN claimed
EP-1117663-A2 2-PIPERAZINO ALKYLAMINO BENZOAZOLE DERIVATIVES: DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS NEUROGEN CORPORATION (US) 2001-07-25 EP claimed
WO-2000018767-A9 2-PIPERAZINO ALKYLAMINO BENZOAZOLE DERIVATIVES: DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS NEUROGEN CORP (US) 2001-04-19 WO claimed
WO-2000018767-A2 2-PIPERAZINO ALKYLAMINO BENZOAZOLE DERIVATIVES: DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS NEUROGEN CORPORATION (US) 2000-04-06 WO claimed
EP-1117663-A2 2-PIPERAZINO ALKYLAMINO BENZOAZOLE DERIVATIVES: DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS NEUROGEN CORPORATION (US) 2001-07-25 EP disclosed
WO-2000018767-A9 2-PIPERAZINO ALKYLAMINO BENZOAZOLE DERIVATIVES: DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS NEUROGEN CORP (US) 2001-04-19 WO disclosed
WO-2000018767-A2 2-PIPERAZINO ALKYLAMINO BENZOAZOLE DERIVATIVES: DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS NEUROGEN CORPORATION (US) 2000-04-06 WO disclosed